News
GLP-1s are revolutionary drugs in the treatment of obesity, but they're very expensive, and this creates a real barrier to people who need access to these drugs.
Our formulary strategy is centered around providing cost-effective, clinically appropriate prescription coverage We remove barriers to care, increase access to new treatments and make them more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results